Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells
- PMID: 1820979
- DOI: 10.1016/0303-7207(91)90262-q
Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells
Abstract
We have examined the effect of androgen treatment on androgen receptor mRNA and protein expression in the LNCaP human prostate carcinoma cell line. Incubation with androgen caused a decrease in cellular androgen receptor mRNA content that was concentration and time dependent. Maximal suppression to approximately 35% of control level was observed after 49 h of exposure to androgen. By contrast, incubation of LNCaP cells with androgen resulted in a 2-fold increase in the cellular content of androgen receptor protein at 24 h. At 49 h androgen receptor protein increased 30% as assayed by immunoblots and 79% as assayed by ligand binding. These results suggest that ligand-induced changes in androgen receptor stability and/or the translational efficiency of androgen receptor mRNA account for the phenomenon of androgen receptor upregulation observed in cultured LNCaP cells. Furthermore, the suppression of androgen mRNA and protein that is caused by prolonged incubation with androgen is incomplete and is reversible upon removal of ligand.
Similar articles
-
Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaP.Mol Cell Endocrinol. 1994 Sep;104(2):153-62. doi: 10.1016/0303-7207(94)90118-x. Mol Cell Endocrinol. 1994. PMID: 7527352
-
Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.Cancer Res. 1997 Mar 15;57(6):1086-90. Cancer Res. 1997. PMID: 9067276
-
Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.Cancer Res. 2001 Apr 1;61(7):2892-8. Cancer Res. 2001. PMID: 11306464
-
Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.J Steroid Biochem Mol Biol. 1995 Oct;55(1):67-76. doi: 10.1016/0960-0760(95)00155-s. J Steroid Biochem Mol Biol. 1995. PMID: 7577722
-
Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.Clin Cancer Res. 2000 Aug;6(8):3241-8. Clin Cancer Res. 2000. PMID: 10955810
Cited by
-
Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.Br J Cancer. 2000 Jan;82(1):39-45. doi: 10.1054/bjoc.1999.0874. Br J Cancer. 2000. PMID: 10638964 Free PMC article.
-
Hunterian Lecture. Characterisation of human prostate epithelial progenitor differentiation in response to androgens.Ann R Coll Surg Engl. 2011 Sep;93(6):424-8. doi: 10.1308/10.1308/147870811x589245. Ann R Coll Surg Engl. 2011. PMID: 21929909 Free PMC article.
-
Emerging role of testosterone in pancreatic β cell function and insulin secretion.J Endocrinol. 2019 Mar;240(3):R97-R105. doi: 10.1530/JOE-18-0573. J Endocrinol. 2019. PMID: 30601759 Free PMC article. Review.
-
Clinical relevance of androgen receptor alterations in prostate cancer.Endocr Connect. 2017 Nov;6(8):R146-R161. doi: 10.1530/EC-17-0118. Endocr Connect. 2017. PMID: 29030409 Free PMC article. Review.
-
Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.BMC Cancer. 2016 Jul 4;16:377. doi: 10.1186/s12885-016-2453-4. BMC Cancer. 2016. PMID: 27378372 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources